The five symposia focused on the field of innovative medical apparatus, focusing on national policies, enterprise research and development, product application, medical insurance payment and other specific content, covering every key link of innovative medical apparatus from R & D to application, from policy to market in an all-round and full chain. It conveyed the strong determination and clear direction of decision-makers to support the development of innovative medical apparatus.

Innovative medical apparatus, as a key driving force for the upgrading of the national medical industry, has always attracted much attention.

early this year, the state shortened the time limit for the review and approval of clinical trials of innovative pharmaceutical devices from 60 working days to 30 working days, pressing the "acceleration button" for the listing of innovative pharmaceutical devices. In the first half of the year, 45 innovative medical apparatus were approved for listing, an increase of 87.5% compared with the same period last year.

Obviously, under the national chain-wide support policy, our country's innovative medical apparatus is standing at a key node of explosive development. Whether it can seize the opportunity and lay out innovative products with high clinical value in advance will be a key factor in determining future development for medical apparatus enterprises and distributors.